Annual Operating Expenses
$368.61 M
+$84.77 M+29.87%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual total operating expenses is $368.61 million, with the most recent change of +$84.77 million (+29.87%) on December 31, 2023.
- During the last 3 years, CORT annual operating expenses has risen by +$148.52 million (+67.48%).
- CORT annual operating expenses is now at all-time high.
Performance
CORT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$133.08 M
+$7.40 M+5.89%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly total operating expenses is $133.08 million, with the most recent change of +$7.40 million (+5.89%) on September 30, 2024.
- Over the past year, CORT quarterly operating expenses has increased by +$18.31 million (+15.95%).
- CORT quarterly operating expenses is now at all-time high.
Performance
CORT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CORT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.9% | +15.9% |
| 3 y3 years | +67.5% | +68.3% |
| 5 y5 years | +135.5% | +68.3% |
CORT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.0% | at high | +118.9% |
| 5 y | 5-year | at high | +94.7% | at high | +158.7% |
| alltime | all time | at high | +4504.2% | at high | +6714.2% |
Corcept Therapeutics Incorporated Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $133.08 M(+5.9%) |
| Jun 2024 | - | $125.68 M(+9.5%) |
| Mar 2024 | - | $114.77 M(+12.7%) |
| Dec 2023 | $368.61 M(+29.9%) | $101.86 M(+12.2%) |
| Sep 2023 | - | $90.78 M(+4.9%) |
| Jun 2023 | - | $86.56 M(-3.2%) |
| Mar 2023 | - | $89.42 M(+13.1%) |
| Dec 2022 | $283.84 M(+20.2%) | $79.08 M(+15.5%) |
| Sep 2022 | - | $68.45 M(-3.1%) |
| Jun 2022 | - | $70.64 M(+7.6%) |
| Mar 2022 | - | $65.67 M(+8.0%) |
| Dec 2021 | $236.22 M(+7.3%) | $60.80 M(+3.7%) |
| Sep 2021 | - | $58.62 M(+0.6%) |
| Jun 2021 | - | $58.26 M(-0.5%) |
| Mar 2021 | - | $58.53 M(+8.4%) |
| Dec 2020 | $220.09 M(+16.2%) | $53.97 M(-10.6%) |
| Sep 2020 | - | $60.39 M(+16.0%) |
| Jun 2020 | - | $52.07 M(-3.0%) |
| Mar 2020 | - | $53.66 M(+4.3%) |
| Dec 2019 | $189.38 M(+21.0%) | $51.44 M(+9.3%) |
| Sep 2019 | - | $47.05 M(+1.7%) |
| Jun 2019 | - | $46.25 M(+3.6%) |
| Mar 2019 | - | $44.63 M(+10.6%) |
| Dec 2018 | $156.54 M(+52.3%) | $40.35 M(+0.5%) |
| Sep 2018 | - | $40.17 M(-0.9%) |
| Jun 2018 | - | $40.52 M(+14.2%) |
| Mar 2018 | - | $35.49 M(+16.6%) |
| Dec 2017 | $102.79 M(+48.8%) | $30.43 M(+8.0%) |
| Sep 2017 | - | $28.16 M(+28.1%) |
| Jun 2017 | - | $21.99 M(-1.0%) |
| Mar 2017 | - | $22.21 M(+21.8%) |
| Dec 2016 | $69.08 M(+31.9%) | $18.24 M(+1.4%) |
| Sep 2016 | - | $17.98 M(+1.1%) |
| Jun 2016 | - | $17.79 M(+18.1%) |
| Mar 2016 | - | $15.07 M(+16.3%) |
| Dec 2015 | $52.37 M(-1.7%) | $12.95 M(+0.4%) |
| Sep 2015 | - | $12.90 M(+1.7%) |
| Jun 2015 | - | $12.68 M(-8.3%) |
| Mar 2015 | - | $13.83 M(+16.9%) |
| Dec 2014 | $53.29 M(+3.1%) | $11.83 M(-2.6%) |
| Sep 2014 | - | $12.15 M(-0.5%) |
| Jun 2014 | - | $12.22 M(-28.5%) |
| Mar 2014 | - | $17.09 M(+21.3%) |
| Dec 2013 | $51.71 M | $14.08 M(+14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $12.33 M(-2.5%) |
| Jun 2013 | - | $12.65 M(+0.1%) |
| Mar 2013 | - | $12.64 M(+11.5%) |
| Dec 2012 | $39.49 M(+22.1%) | $11.34 M(+30.3%) |
| Sep 2012 | - | $8.70 M(+3.4%) |
| Jun 2012 | - | $8.42 M(-23.7%) |
| Mar 2012 | - | $11.03 M(+11.1%) |
| Dec 2011 | $32.33 M(+17.8%) | $9.93 M(+54.2%) |
| Sep 2011 | - | $6.44 M(-27.4%) |
| Jun 2011 | - | $8.87 M(+25.0%) |
| Mar 2011 | - | $7.10 M(-9.3%) |
| Dec 2010 | $27.44 M(+35.3%) | $7.82 M(+10.1%) |
| Sep 2010 | - | $7.11 M(+10.2%) |
| Jun 2010 | - | $6.45 M(+6.3%) |
| Mar 2010 | - | $6.06 M(+17.5%) |
| Dec 2009 | $20.28 M(+1.9%) | $5.16 M(+10.6%) |
| Sep 2009 | - | $4.67 M(-4.5%) |
| Jun 2009 | - | $4.89 M(-12.1%) |
| Mar 2009 | - | $5.56 M(-9.8%) |
| Dec 2008 | $19.90 M(+56.3%) | $6.16 M(+24.0%) |
| Sep 2008 | - | $4.97 M(+6.0%) |
| Jun 2008 | - | $4.69 M(+14.8%) |
| Mar 2008 | - | $4.08 M(-7.6%) |
| Dec 2007 | $12.73 M(-50.8%) | $4.42 M(+22.1%) |
| Sep 2007 | - | $3.62 M(+85.3%) |
| Jun 2007 | - | $1.95 M(-28.6%) |
| Mar 2007 | - | $2.74 M(-32.7%) |
| Dec 2006 | $25.88 M(+22.3%) | $4.06 M(-37.9%) |
| Sep 2006 | - | $6.55 M(-19.8%) |
| Jun 2006 | - | $8.16 M(+15.0%) |
| Mar 2006 | - | $7.10 M(+29.0%) |
| Dec 2005 | $21.16 M(+31.9%) | $5.50 M(+0.4%) |
| Sep 2005 | - | $5.48 M(+25.0%) |
| Jun 2005 | - | $4.39 M(-24.2%) |
| Mar 2005 | - | $5.79 M(+4.8%) |
| Dec 2004 | $16.05 M(+60.9%) | $5.52 M(+29.7%) |
| Sep 2004 | - | $4.26 M(+15.3%) |
| Jun 2004 | - | $3.69 M(+43.8%) |
| Mar 2004 | - | $2.57 M(+27.3%) |
| Dec 2003 | $9.97 M(-47.0%) | $2.02 M(-6.7%) |
| Sep 2003 | - | $2.16 M(-26.0%) |
| Jun 2003 | - | $2.92 M(+2.0%) |
| Mar 2003 | - | $2.87 M |
| Dec 2002 | $18.80 M(+134.8%) | - |
| Dec 2001 | $8.01 M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual operating expenses year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly operating expenses year-on-year change?
What is Corcept Therapeutics Incorporated annual total operating expenses?
The current annual operating expenses of CORT is $368.61 M
What is the all time high annual operating expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total operating expenses is $368.61 M
What is Corcept Therapeutics Incorporated annual operating expenses year-on-year change?
Over the past year, CORT annual total operating expenses has changed by +$84.77 M (+29.87%)
What is Corcept Therapeutics Incorporated quarterly total operating expenses?
The current quarterly operating expenses of CORT is $133.08 M
What is the all time high quarterly operating expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total operating expenses is $133.08 M
What is Corcept Therapeutics Incorporated quarterly operating expenses year-on-year change?
Over the past year, CORT quarterly total operating expenses has changed by +$18.31 M (+15.95%)